Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Adjuvant AI Combined With Zoladex
- First Posted Date
- 2011-05-11
- Last Posted Date
- 2011-05-11
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 670
- Registration Number
- NCT01352091
- Locations
- 🇨🇳
FUSCC, Shanghai, Shanghai, China
Health-related Quality of Life of Patients With Esophageal Cancer After Surgery
- First Posted Date
- 2011-05-06
- Last Posted Date
- 2011-11-11
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 400
- Registration Number
- NCT01349517
- Locations
- 🇨🇳
Zhong Shan Hospital, Fu Dan University, Shanghai, Shanghai, China
Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck
- First Posted Date
- 2011-04-12
- Last Posted Date
- 2013-03-05
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 32
- Registration Number
- NCT01333696
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma
- First Posted Date
- 2011-04-12
- Last Posted Date
- 2013-03-05
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 43
- Registration Number
- NCT01333605
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer
- First Posted Date
- 2011-03-24
- Last Posted Date
- 2013-06-11
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 52
- Registration Number
- NCT01322152
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients
Phase 2
- Conditions
- First Posted Date
- 2011-03-24
- Last Posted Date
- 2011-08-12
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 90
- Registration Number
- NCT01322178
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-03-15
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1570
- Registration Number
- NCT01314833
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
The Effect of Zoledronic Acid to Bone Fusion and Bone Metabolism of Patients With Lumbar Degenerative Disease After Lumbar Interbody Fusion
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2011-03-08
- Last Posted Date
- 2011-03-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 50
- Registration Number
- NCT01310465
- Locations
- 🇨🇳
Zhongshan hospital of Fudan university, Shanghai, Shanghai, China
Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer
- First Posted Date
- 2011-03-08
- Last Posted Date
- 2011-03-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 15
- Registration Number
- NCT01310478
- Locations
- 🇨🇳
Shanghai Cancer Center, Shanghai, Shanghai, China
Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2011-03-08
- Last Posted Date
- 2011-03-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 50
- Registration Number
- NCT01310452
- Locations
- 🇨🇳
Zhong Shan Hospital, Fudan University, Shang hai, China
© Copyright 2024. All Rights Reserved by MedPath